glp-1 yeast infection glp 1 Diabetes mellitus, vaginal microbiome and sexual function: Outcomes in postmenopausal women The Interplay Between GLP-1-Based Therapies,

Description

Patients who take these medications say: They have fewer cravings

No need to manually update your subscription our care team will handle all adjustments for you during the call

Weight regain after discontinuation is common, with studies showing 60-70% of lost weight returning within a year of stopping

The submission is supported by the SURPASS-CVOT trial, which showed that Mounjaro reduced the risk of MACEincluding CV death, heart attack, or strokeby 8% compared with Trulicity (p=0.086), demonstrating noninferiority to Trulicity regarding CV risk

Though intuitively, people should prefer a pill over an injection, in my experience, patients are willing to take the weekly injection if it provides more robust weight and A1C lowering outcomes, says Tan